1. Home
  2. Analysis
  3. Diastat
  4. Triamcinolone-acetonide

Diastat and Triamcinolone acetonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 14 people who take Diastat and Triamcinolone acetonide. Common interactions include sinusitis among males.

The phase IV clinical study analyzes what interactions people who take Diastat and Triamcinolone acetonide have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

14 people who take Diastat and Triamcinolone acetonide together, and have interactions are studied.

What is Diastat?

Diastat has active ingredients of diazepam. Currently, eHealthMe is studying from 1,994 Diastat users.

What is Triamcinolone acetonide?

Triamcinolone acetonide has active ingredients of triamcinolone acetonide. It is used in eczema. Currently, eHealthMe is studying from 16,556 Triamcinolone acetonide users.

Number of Diastat and Triamcinolone acetonide reports submitted per year:

Diastat and Triamcinolone acetonide drug interactions.

Common Diastat and Triamcinolone Acetonide drug interactions by gender *:

female:

n/a

male:

  1. Sinusitis
  2. Productive cough
  3. Alopecia
  4. Anxiety
  5. Blood cholesterol increased
  6. Blood sodium decreased
  7. Blood triglycerides increased
  8. Brain injury
  9. Bronchitis
  10. Cerebral palsy

Common Diastat and Triamcinolone Acetonide drug interactions by age *:

0-1:

n/a

2-9:

  1. Diarrhoea
  2. Nasopharyngitis
  3. Drug level increased
  4. Dysphonia
  5. Ear congestion
  6. Ear infection
  7. Eating disorder
  8. Headache
  9. Hospitalisation
  10. Hypersomnia

10-19:

  1. Brain injury
  2. Bronchitis
  3. Cerebral palsy
  4. Constipation
  5. Dysphagia
  6. Gait disturbance
  7. Laryngospasm
  8. Muscle spasticity
  9. Nasopharyngitis
  10. Periventricular leukomalacia

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

Common conditions people have *:

  1. Immunodeficiency Common Variable: 2 people, 14.29%
  2. Idiopathic Generalised Epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis): 2 people, 14.29%
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 14.29%
  4. Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 1 person, 7.14%
  5. Brain Neoplasm Benign (non-cancerous tumour of brain): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Diastat and Triamcinolone acetonide?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Diastat drug interactions:

Browse interactions between Diastat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Triamcinolone acetonide drug interactions:

Browse interactions between Triamcinolone acetonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diazepam and triamcinolone acetonide (the active ingredients of Diastat and Triamcinolone acetonide, respectively), and Diastat and Triamcinolone acetonide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Diastat and Triamcinolone acetonide.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.